Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Apr 16 2024

Apr 16, 2024 at 2:40 PM UTC

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated April 16, 2024, titled "Press Release on USFDA approval on Ofloxacin Ophthalmic Solution ANDA".

View Attachment